Can a drop of bone cement keep hip fracture repairs from failing?

NCT ID NCT06634290

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This trial tests whether adding bone cement to the standard metal nail used in hip fracture surgery helps the repair hold together better. People aged 75 and older with a certain type of hip fracture will be randomly assigned to receive either the standard surgery or the surgery with cement added. The researchers will track how many patients need a second operation because the implant failed, and they will also monitor survival rates over the following year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intramedullary nailing with cephalic augmentation using bone cement
What this could lead to
If adding bone cement to the nail improves stability, it could reduce the need for repeat surgery and improve recovery for elderly patients with hip fractures.
What could go wrong
The trial is early and may not show a clear benefit. Adding cement could also carry risks such as cement leakage or increased surgical complexity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 314 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

75 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 75 years of age or older. * Diagnosis with a pertrochanteric fragility fracture. * Informed consent for participation in the study. Exclusion Criteria: * Not meeting the inclusion criteria described above. * Refusal of the patient or his/her legal representative to participate in the study. * Diagnosis with hip fracture of subtypes other than 31A1, 31A2, 31A3 and 31B3 of AO-OTA classification. * Bilateral hip fractures in the same episode. * Suffering from previous medical pathologies or comorbidities that contraindicate surgical intervention and indicate conservative management of the fracture. * Performing a surgical technique different from intramedullary nailing or using a surgical implant different from that used in the present study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fracture of intertrochanteric type are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Complexo Hospitalario Pontevedra

    RECRUITING

    Pontevedra, 36071, Spain

  • Complexo Hospitalario Universitario de Ourense

    RECRUITING

    Ourense, 32005, Spain

  • Complexo Hospitalario Universitario de Vigo

    RECRUITING

    Vigo, Pontevedra, 36312, Spain

  • Hospital de Monforte de Lemos

    RECRUITING

    Monforte de Lemos, Lugo, 27400, Spain

  • Hospital de Verin

    RECRUITING

    Verín, Ourense, 32600, Spain

  • Hospital do Salnes

    RECRUITING

    Vilagarcía de Arousa, Pontevedra, 36619, Spain